Let’s start up with the current stock price of Revelation Biosciences Inc. (REVB), which is $1.91 to be very precise. The Stock rose vividly during the last session to $2.13 after opening rate of $1.74 while the lowest price it went was recorded $1.63 before closing at $1.74.Recently in News on March 13, 2023, Revelation Biosciences Inc. Appoints Dr. Julia Bohannon and Dr. Antonio Hernandez to Scientific Advisory Board. Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a life sciences company that is focused on the development of immunologic-based therapies for the prevention and treatment of disease, today announced it has appointed Julia Bohannon, Ph.D. and Antonio Hernandez, M.D. to its scientific advisory board. Dr. Hernandez and Dr. Bohannon are inventors of the phosphorylated hexaacyl disaccharide (PHAD) based technology licensed from Vanderbilt University, previously announced on October 6, 2022. You can read further details here
Revelation Biosciences Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $100.8000 on 03/25/22, with the lowest value was $1.5500 for the same time period, recorded on 03/10/23.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Sponsored
Revelation Biosciences Inc. (REVB) full year performance was -95.30%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Revelation Biosciences Inc. shares are logging -98.11% during the 52-week period from high price, and 23.23% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.55 and $100.80.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 2194712 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Revelation Biosciences Inc. (REVB) recorded performance in the market was -71.29%, having the revenues showcasing -72.16% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 1.32M, as it employees total of 14 workers.
The Analysts eye on Revelation Biosciences Inc. (REVB)
During the last month, 0 analysts gave the Revelation Biosciences Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 6.7918, with a change in the price was noted -6.89. In a similar fashion, Revelation Biosciences Inc. posted a movement of -78.28% for the period of last 100 days, recording 157,403 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for REVB is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical rundown of Revelation Biosciences Inc. (REVB)
Raw Stochastic average of Revelation Biosciences Inc. in the period of last 50 days is set at 3.66%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 26.09%. In the last 20 days, the company’s Stochastic %K was 17.19% and its Stochastic %D was recorded 10.58%.
Considering, the past performance of Revelation Biosciences Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -71.29%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -86.99%, alongside a downfall of -95.30% for the period of the last 12 months. The shares increased approximately by -9.05% in the 7-day charts and went up by -32.98% in the period of the last 30 days. Common stock shares were lifted by -72.16% during last recorded quarter.
